Antipsychotic Agents: all 1,683 studies that test it
Page 17 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- A Study of Adjunctive Aripiprazole in Participants With Major Depressive DisorderCompletedNCT00095758Phase 3
- Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With DementiaCompletedNCT00095719Phase 3
- Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderCompletedNCT00095524Phase 3
- Aripiprazole in Patients With Acute ManiaCompletedNCT00095511Phase 3
- Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard TherapyCompletedNCT00095134Phase 3
- A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.CompletedNCT00094926Phase 3
- Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00094549Phase 4
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeCompletedNCT00094432Phase 3
- Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00091650Phase 3
- Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With SchizophreniaCompletedNCT00090324Phase 3
- Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaCompletedNCT00090311Phase 3
- Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00090012Phase 4
- Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Status unknownNCT00089440Phase 1
- Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With SchizophreniaCompletedNCT00088491Phase 3
- Investigate Risperidone for the Treatment of Schizophrenia in AdolescentsCompletedNCT00088075Phase 3
- Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaCompletedNCT00088049Phase 4
- Efficacy and Safety of Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00088036Phase 3
- Interaction Between Cocaine and Quetiapine - 1Status unknownNCT00087750Phase 1
- Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational DrugCompletedNCT00087542Phase 2
- A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.CompletedNCT00086320Phase 3
- ACP-103 to Treat Parkinson's DiseaseCompletedNCT00086294Phase 2
- Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.CompletedNCT00086112Phase 3
- Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00085891Phase 3
- Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With SchizophreniaCompletedNCT00085748Phase 3
- Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar DepressionCompletedNCT00083954Phase 3
- Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaCompletedNCT00083668Phase 3
- Study of Aripiprazole in Subjects With AlcoholismCompletedNCT00082199Phase 4
- Study of Three Doses of Aripiprazole in Patients With Acute SchizophreniaCompletedNCT00080327Phase 4
- Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression EpisodeCompletedNCT00080314Phase 3
- Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaCompletedNCT00078039Phase 3
- Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With SchizophreniaCompletedNCT00077714Phase 3
- Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and AdolescentsCompletedNCT00076115Phase 3
- Safety and Efficacy of an Anti-Psychotic in Patients With SchizophreniaCompletedNCT00074477Phase 2
- Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With SchizophreniaCompletedNCT00073320Phase 3
- Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar IllnessTerminatedNCT00071253Phase 4
- Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective DisorderCompletedNCT00061802Phase 4
- Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar DepressionCompletedNCT00060489Phase 3
- A Controlled Study of Olanzapine in Children With AutismCompletedNCT00057408Phase 2
- Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaCompletedNCT00051298Phase 3
- Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I DisorderCompletedNCT00050206Phase 4
- Schizophrenia Study In AdultsCompletedNCT00049946Phase 2
- Treating Drug-Resistant Childhood SchizophreniaCompletedNCT00048828Phase 4
- Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar DisorderCompletedNCT00046384Phase 3
- A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant DepressionCompletedNCT00044681Phase 3
- Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)CompletedNCT00043849Phase 4
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00041678Phase 3
- Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and AdolescentsCompletedNCT00036582Phase 3
- Broad Effectiveness: Study With AripiprazoleCompletedNCT00036361Phase 3
- Study of Aripiprazole in Patients With a History of Bipolar DisorderCompletedNCT00036348Phase 3
- Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic DisordersCompletedNCT00036127Phase 2/3
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00036114Phase 3
- Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar DisorderCompletedNCT00036101Phase 3
- Olanzapine Versus An Active Comparator in the Treatment of SchizophreniaCompletedNCT00036088Phase 4
- The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCompletedNCT00035321Phase 3
- CAFE Comparison of Atypicals in First Episode of PsychosisCompletedNCT00034892Phase 3
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCompletedNCT00034801Phase 4
- A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.CompletedNCT00034775Phase 3
- Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's DiseaseCompletedNCT00034762Phase 3
- The Efficacy and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCompletedNCT00034749Phase 3
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I DisorderCompletedNCT00034580Phase 4
- Reserpine for the Treatment of Cocaine Dependence - 1CompletedNCT00033033Phase 2
- Clozapine for Treatment-Resistant ManiaCompletedNCT00029458Phase 2
- Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00018642Not applicable
- Treatment of Behavioral Symptoms in Alzheimer's DiseaseCompletedNCT00009217Phase 4
- To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaCompletedNCT00007774Phase 4
- Glucose Regulation During Risperidone and Olanzapine TreatmentStatus unknownNCT00006195Not applicable
- Treatment of Autism in Children and AdolescentsCompletedNCT00005014Phase 3
- Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's DiseaseCompletedNCT00004826Not applicable
- Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette SyndromeCompletedNCT00004652Phase 2
- Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette SyndromeCompletedNCT00004393Phase 2
- Infusion Laboratory: Protocol 5 (Flupenthixol) - 14Status unknownNCT00000349Phase 1
- Risperidone for Treatment of Cocaine Dependence in Outpatients - 12CompletedNCT00000347Phase 2
- Risperidone for the Treatment of Cocaine Dependence - 7CompletedNCT00000342Phase 2
- Infusion Laboratory: Protocol 3 (Risperidone) - 4Status unknownNCT00000339Phase 1
- Early Phase II Trials for Cocaine Medication Development - 1CompletedNCT00000317Phase 2
- Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2TerminatedNCT00000310Phase 2
- Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1TerminatedNCT00000309Phase 2
- Cocaine Abuse and ADHD - 10CompletedNCT00000275Phase 2
- Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9CompletedNCT00000274Phase 2
- Risperidone Treatment in Dually-Diagnosed Individuals - 2CompletedNCT00000267Phase 2
- Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1CompletedNCT00000266Phase 2
- Flupenthixol Decanoate in Methamphetamine Smoking - 1CompletedNCT00000241Phase 2
- Ritanserin in Treatment of Cocaine Dependence - 1CompletedNCT00000187Phase 2